Phase I study of stereotactic radiotherapy for unresectable primary and metastatic liver cancer

被引：1
|
作者：
Dawson, L. [1 ]
Hawkins, M. [1 ]
Eccles, C. [1 ]
Craig, T. [1 ]
Bissonnette, J-P. [1 ]
Lockwood, G. [1 ]
Zhang, J. [1 ]
Kim, J. [1 ]
Cummings, B. [1 ]
Sherman, M. [1 ]
Knox, J. [1 ]
Gallinger, S. [1 ]
机构：
[1] Univ Toronto, Princess Margaret Hosp, Toronto, ON M4X 1K9, Canada
来源：
RADIOTHERAPY AND ONCOLOGY | 2006年 / 80卷
关键词：
D O I：
10.1016/S0167-8140(06)80805-4
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
64
引用
收藏
页码：S19 / S20
页数：2
相关论文
共 50 条
  • [41] Phase I study of a chloroquine-gemcitabine combination in patients with metastatic or unresectable pancreatic cancer
    Samaras, Panagiotis
    Tusup, Marina
    Thi Dan Linh Nguyen-Kim
    Seifert, Burkhardt
    Bachmann, Helga
    von Moos, Roger
    Knuth, Alexander
    Pascolo, Steve
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2017, 80 (05) : 1005 - 1012
  • [42] SYSTEMATIC REVIEW OF PATIENT REPORTED QUALITY OF LIFE FOLLOWING STEREOTACTIC ABLATIVE BODY RADIOTHERAPY FOR PRIMARY AND METASTATIC LIVER CANCER
    Mutsaers, Adam
    Greenspoon, Jeffrey
    Walker-Dilks, Cindy
    Swaminath, Anand
    RADIOTHERAPY AND ONCOLOGY, 2016, 120 : S62 - S62
  • [43] Stereotactic radiotherapy of primary liver tumors and livermetastases
    Bostel, Tilman
    Bremer, Michael
    ONKOLOGIE, 2022, 28 (04): : 318 - 325
  • [44] Stereotactic radiotherapy for primary lung cancer
    Phillips, I.
    Flint, R.
    Hin, B.
    Ezhil, V.
    CLINICAL ONCOLOGY, 2017, 29 : S10 - S11
  • [45] Phase I clinical trial of oral Furtulon and combined hepatic arterial chemoembolization and radiotherapy in unresectable primary liver cancers, including clinicopathologic study
    Zeng, ZC
    Tang, ZY
    Wu, ZQ
    Ma, ZC
    Fan, J
    Qin, LX
    Zhou, J
    Wang, JH
    Wang, BL
    Zhong, CS
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2000, 23 (05): : 449 - 454
  • [46] Outcomes and toxicity of stereotactic radiotherapy for metastatic breast cancer - a retrospective study
    AL-Hanaqta, M.
    Niglas, M.
    Jiang, C.
    Cheung, P.
    Chu, W.
    Chung, H.
    Myrehaug, S.
    Poon, I.
    Sahgal, A.
    Soliman, H.
    RADIOTHERAPY AND ONCOLOGY, 2019, 133 : S697 - S697
  • [47] Stereotactic radiotherapy in metastatic breast cancer patients - a multicenter cohort study
    Fabian, Alexander
    Buergy, Daniel
    Amirpour-Mehrhof, Nora
    Bernhardt, Denise
    Bicu, Alicia S.
    Ferentinos, Konstantinos
    Gkika, Eleni
    Hemmatazad, Hossein
    Hintelmann, Katharina
    Hoerner-Rieber, Juliane
    Janssen, Stefan
    Karle, Heiko
    Kaul, David
    Lange, Tim
    Pazos, Montserrat
    Rogers, Susanne
    Badra, Eugenia Vlaskou
    Weykamp, Fabian
    Brunner, Thomas
    Wittig, Andrea
    Nona-Duma, Marciana
    Blanck, Oliver
    Krug, David
    RADIOTHERAPY AND ONCOLOGY, 2024, 194 : S559 - S562
  • [48] Hypofractionated stereotactic radiotherapy for primary and secondary intrapulmonary tumors - First results of a phase I/II study
    Ernst-Stecken, Antje
    Lambrecht, Ulrike
    Mueller, Reinhold
    Sauer, Rolf
    Grabenbauer, Gerhard
    STRAHLENTHERAPIE UND ONKOLOGIE, 2006, 182 (12) : 696 - 702
  • [49] Clinical outcomes of a phase I/II study of 48 Gy of stereotactic body radiotherapy in 4 fractions for primary lung cancer using a stereotactic body frame
    Nagata, Y
    Takayama, K
    Matsuo, Y
    Norihisa, Y
    Mizowaki, T
    Sakamoto, T
    Sakamoto, M
    Mitsumori, M
    Shibuya, K
    Araki, N
    Yano, S
    Hiraoka, M
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 63 (05): : 1427 - 1431
  • [50] Phase I Study of Stereotactic Body Radiotherapy followed by Ipilimumab with Nivolumab vs. Nivolumab alone in Unresectable Hepatocellular Carcinoma
    Juloori, A.
    Liao, C. Y.
    Lemons, J. M.
    Singh, A. K.
    Iyer, R.
    Robbins, J. R.
    George, B.
    Fung, J.
    Pillai, A.
    Arif, F.
    Sharma, M.
    Liauw, S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : S149 - S150
12345